KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Free Cash Flow (2016 - 2025)

Eli Lilly (LLY) has disclosed Free Cash Flow for 17 consecutive years, with $677.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow fell 30.66% year-over-year to $677.9 million, compared with a TTM value of $9.0 billion through Dec 2025, up 138.62%, and an annual FY2025 reading of $9.0 billion, up 138.62% over the prior year.
  • Free Cash Flow was $677.9 million for Q4 2025 at Eli Lilly, down from $6.7 billion in the prior quarter.
  • Across five years, Free Cash Flow topped out at $6.7 billion in Q3 2025 and bottomed at -$1.4 billion in Q4 2023.
  • Average Free Cash Flow over 5 years is $1.3 billion, with a median of $1.2 billion recorded in 2022.
  • The sharpest move saw Free Cash Flow skyrocketed 1025.79% in 2021, then plummeted 219.02% in 2023.
  • Year by year, Free Cash Flow stood at $2.0 billion in 2021, then crashed by 41.02% to $1.2 billion in 2022, then tumbled by 219.02% to -$1.4 billion in 2023, then skyrocketed by 170.69% to $977.7 million in 2024, then plummeted by 30.66% to $677.9 million in 2025.
  • Business Quant data shows Free Cash Flow for LLY at $677.9 million in Q4 2025, $6.7 billion in Q3 2025, and $1.4 billion in Q2 2025.